REGULATION OF AN EXTRACELLULAR XENOBIOTIC RESPONSE GENE
REGULATION OF AN EXTRACELLULAR XENOBIOTIC RESPONSE GENE
批准号:
6077954
负责人:
Bruce J Aronow
金额:
$30.56万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 2001-09-29
关键词:
apolipoproteins brain cellular pathology chloramphenicol acetyltransferase cytoprotection cytotoxicity environmental toxicology fusion gene gene expression gene induction /repression gene targeting genetic regulation genetically modified animals kidney laboratory mouse male reproductive system nucleic acid sequence reporter genes tissues toxin metabolism
中文摘要
描述:(改编自《调查者摘要》)
组织对外源致伤物质的耐受能力取决于
细胞合成保护和修复所需的新基因产物。
ApoJ--一种进化上保守的分泌型糖蛋白
多种疏水分子,已被多名研究人员克隆
研究暴露于外源药物的组织中新的基因表达
诱导损伤或细胞凋亡。有人提议发挥作用,在
在病理条件下的细胞保护,并强烈表达
病变周围的细胞。ApoJ也是根据宪法表达的,并且
在一系列有趣的上皮细胞中发育,通常在
液体-组织边界的界面。因此,apoJ是一个表达的基因
在正常和病理生理学的关键生物学界面上
情况。为了检验apoJ促进细胞外的假设
损伤修复,研究人员建议将损伤修复描述为
他们产生的apoJ-空基因敲除小鼠。因为很多基因都是
由异种组织损伤激活的apoJ将成为理想的模型
定义由组织损伤引起的基因诱导机制。第一个具体
AIM将检验载脂蛋白J具有细胞保护功能的假设
异种组织损伤的部位。为此,apoJ NULL的能力
基因敲除和野生型小鼠将承受异种组织损伤
比较一下。此外,载脂蛋白J在肾脏、脑和男性生殖中的作用
三种不同化学制剂诱导的肠道损伤模型
将评估组织特异性损伤和apoJ的表达。因为.
它在许多组织中都可以被各种异源物质诱导,它
假设有一种共同的机制通过
异种生物损伤。为了验证这一假设,研究人员将使用
嵌合ApoJ-CAT报告基因用于鉴定ApoJ-CAT的序列和元件
在三种损伤中负责激活基因表达的apoJ基因
目标1中要研究的模型。如果相同的控制序列
负责对每个组织中的每个损伤的反应,这将
提示apoJ基因可以作为鉴定的原型。
新的和基本的伤害反应机制。从以下方面获得的知识
这些研究将确定载脂蛋白J在损伤反应中的重要性,提供
它可能与其他几个基因敲除相结合的基础
影响边界界面的伤害反应,并将允许
识别允许细胞作出反应的重要遗传机制
在下列情况下防止和抵御外来生物的有害影响
完好无损的动物。
英文摘要
DESCRIPTION: (Adapted from the Investigator's Abstract) The ability of a
tissue to withstand injury-inducing xenobiotics depends on the ability of
cells to synthesize new gene products necessary for protection and repair.
ApoJ, an evolutionarily conserved secretory glycoprotein capable of binding
diverse hydrophobic molecules, has been cloned by multiple investigators
studying new gene expression in tissues exposed to xenobiotic agents that
induce injury or apoptosis. It has been proposed to play a role in
cytoprotection during pathological conditions and is strongly expressed by
cells that surround lesions. ApoJ is also expressed constitutively and
developmentally in an interesting series of epithelial cells frequently at
the interfaces of fluid-tissue boundaries. Thus, apoJ is a gene expressed
at critical biological interfaces in both normal and pathophysiologic
circumstances. To test the hypothesis that apoJ promotes extracellular
injury repair, the investigators propose to characterize injury repair in
apoJ-null knockout mice that they have generated. Since many genes are
activated by xenobiotic tissue injury, apoJ will serve as an ideal model to
define mechanisms for gene induction by tissue injury. The first specific
aim will test the hypothesis that apoJ has a cytoprotective function at
sites of xenobiotic tissue injury. To do this, the ability of apoJ null
knock-out and wild type mice to withstand xenobiotic tissue injury will be
compared. Additionally, apoJ's role in kidney, brain, and male reproductive
tract injury models in which three different chemical agents induce both
tissue specific injury and apoJ expression will be evaluated. Because of
its inducibility in many tissues by a wide variety of xenobiotic agents, it
is hypothesized that a common mechanism controls gene activation by
xenobiotic injury. To test this hypothesis the investigators will use
chimeric apoJ-CAT reporter transgenes to identify sequences and elements of
the apoJ gene responsible for activating gene expression in the three injury
models to be studied in aim 1. If the same control sequences are
responsible for the responsiveness to each injury in each tissue, this will
suggest that the apoJ gene can serve as a prototype for the identification
of novel and fundamental injury response mechanisms. Knowledge gained from
these studies will define the importance of apoJ in injury response, provide
a foundation for its combination with several other gene knock-outs likely
to affect injury response at boundary interfaces, and will allow the
identification of important genetic mechanisms that allow cells to respond
to and withstand injurious effects of xenobiotics in the context of the
intact animal.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Leveraging the electronic health record to characterize and optimize care delivery for children with cerebral palsy.
-
批准号:10295949
-
项目类别:
-
资助金额:$70.02万
-
财政年份:2021
-
负责人:Bruce J Aronow
-
依托单位:
The LungMAP Data Coordination Center for Next Gen Systems Biology of Respiration
-
批准号:10683113
-
项目类别:
-
资助金额:$145.84万
-
财政年份:2019
-
负责人:Bruce J Aronow
-
依托单位:
The LungMAP Data Coordination Center for Next Gen Systems Biology of Respiration
-
批准号:9815844
-
项目类别:
-
资助金额:$120.63万
-
财政年份:2019
-
负责人:Bruce J Aronow
-
依托单位:
The LungMAP Data Coordination Center for Next Gen Systems Biology of Respiration
-
批准号:10228616
-
项目类别:
-
资助金额:$145.84万
-
财政年份:2019
-
负责人:Bruce J Aronow
-
依托单位:
The LungMAP Data Coordination Center for Next Gen Systems Biology of Respiration
-
批准号:10000983
-
项目类别:
-
资助金额:$145.84万
-
财政年份:2019
-
负责人:Bruce J Aronow
-
依托单位:
The LungMAP Data Coordination Center for Next Gen Systems Biology of Respiration
-
批准号:10461748
-
项目类别:
-
资助金额:$145.84万
-
财政年份:2019
-
负责人:Bruce J Aronow
-
依托单位:
Nextgen Dissection of the Genomic Basis of Kidney Development
-
批准号:8047815
-
项目类别:
-
资助金额:$181.31万
-
财政年份:2010
-
负责人:Bruce J Aronow
-
依托单位:
Gene Analysis Core
-
批准号:10442027
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2007
-
负责人:Bruce J Aronow
-
依托单位:
BIOFORMATICS CORE
-
批准号:8665912
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2007
-
负责人:Bruce J Aronow
-
依托单位:
BIOFORMATICS CORE
-
批准号:8894494
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2007
-
负责人:Bruce J Aronow
-
依托单位:
BIOFORMATICS CORE
-
批准号:8334764
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2007
-
负责人:Bruce J Aronow
-
依托单位:
Gene Analysis Core
-
批准号:10620711
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2007
-
负责人:Bruce J Aronow
-
依托单位:
BIOFORMATICS CORE
-
批准号:9071409
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2007
-
负责人:Bruce J Aronow
-
依托单位:
BIOFORMATICS CORE
-
批准号:8464070
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2007
-
负责人:Bruce J Aronow
-
依托单位:
Core--Bioinformatics
-
批准号:6579914
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:Bruce J Aronow
-
依托单位:
Core--Bioinformatics
-
批准号:6617332
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:Bruce J Aronow
-
依托单位:
Core--Bioinformatics
-
批准号:6618913
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:Bruce J Aronow
-
依托单位:
REGULATION OF AN EXTRACELLULAR XENOBIOTIC RESPONSE GENE
-
批准号:2796655
-
项目类别:
-
资助金额:$30.15万
-
财政年份:1997
-
负责人:Bruce J Aronow
-
依托单位:
REGULATION OF AN EXTRACELLULAR XENOBIOTIC RESPONSE GENE
-
批准号:2019242
-
项目类别:
-
资助金额:$29.55万
-
财政年份:1997
-
负责人:Bruce J Aronow
-
依托单位:
CONTROL OF PURINE CATABOLISM IN THE THYMUS
-
批准号:2444086
-
项目类别:
-
资助金额:$17.8万
-
财政年份:1994
-
负责人:Bruce J Aronow
-
依托单位:
国内基金
海外基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
-
批准号:81801389
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:田茗源
-
依托单位:
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
-
批准号:81101046
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:黄静
-
依托单位: